MAXALT cpr 5 mg 6 pce
7680545900169
CH-54590
N02CC04
02.05.1.
1 / 3
google
Details
- Product number
- 5459001
- CPT
- -
- Packaging group
- 6
- Unit
- Tablette(n)
- Composition
- rizatriptanum 5 mg ut rizatriptani benzoas, lactosum monohydricum 30.25 mg, cellulosum microcristallinum, amylum pregelificatum, magnesii stearas, E 172 (rubrum) pro compresso.
Articles (1)
Maxalt 5 mg, Tabletten
Tabletten
6
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
5.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
30.25 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
Reimbursement information
Public price
CHF 41.35
Specialties list
Yes
Generic
No
SL addition date:
01/02/2001
Authorization holder
Organon GmbH
6006 Luzern
Authorization information
- Swissmedic authorization number
- 54590
- Drug name
- Maxalt, Tabletten
- Galenic form
- TAB
- ATC Code
- N02CC04
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 27/06/2000
- Authorization expiration date
- 31/12/9999
- IT number
- 02.05.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- MAXALT cpr 5 mg 6 pce
- Description (DE)
- MAXALT Tabl 5 mg 6 Stk
- Market launch
- 27/06/2000
- Narcotic (BTM)
- No